A Major Short Squeeze Could Be Brewing in Oklo Stock

A short squeeze is when too many investors bet that a stock’s decline backfires, and even a modest rally can force short sellers to buy shares back, pushing the price higher and creating a self-feeding climb. That setup is now worth watching in small modular reactor stocks, like Oklo (OKLO).

Short sellers have made more than $2 billion betting against three small modular reactor companies like Oklo, NuScale Power Corporation (SMR), and NANO Nuclear Energy (NNE) over the past year, according to S3 Partners, as the nuclear industry’s once-hot stocks lost billions in combined market values. Yet the bearish trade remains crowded. About 16% of Oklo’s outstanding shares are still out on loan, a proxy for short selling. OKLO stock has slipped this year as concerns over the small modular reactor industry have weighed on investor sentiment, leaving the stock under pressure and the short trade firmly in focus.

That is where the story gets interesting. Nuclear sentiment could get a lift from Big Tech’s growing power needs, policy support, and upcoming small modular reactor listings. Meanwhile, Oklo says its Aurora reactor remains on track for commercial operation in 2028. If momentum returns, those heavy short positions could become fuel for an Oklo stock squeeze.

About Oklo Stock

Founded in 2013 and based in Santa Clara, Oklo is a nuclear technology company developing compact fast-fission reactors to deliver reliable, carbon-free power. Founded by MIT graduates Jacob DeWitte and Caroline Cochran, Oklo is targeting growing electricity needs across AI data centers, defense infrastructure, and industrial operations. Its Aurora reactor is designed to provide scalable power with a smaller footprint than traditional nuclear plants.

The company has gained significant investor attention as the artificial intelligence (AI) boom fuels demand for dependable electricity and revives interest in nuclear energy. However, Oklo remains a high-risk, early-stage growth story, with its commercial ambitions still ahead of execution.

With a market cap of roughly $8 billion, Oklo has already cleared several important milestones in the U.S. nuclear sector, including a Department of Energy site-use permit, fuel awards from Idaho National Laboratory, and a landmark advanced reactor license application with the Nuclear Regulatory Commission. But for investors, the bigger story has been the stock’s remarkable volatility.

Since going public through a SPAC merger in 2024, OKLO stock has delivered impressive returns. Shares are still up about 514.5% over the past two years, despite the company remaining pre-revenue. The rally was fueled largely by excitement around AI’s enormous power needs and the possibility that small modular reactors could provide reliable, carbon-free electricity. That optimism pushed OKLO to a high of $193.84 last October.

The mood changed in 2026 as investors began looking beyond the nuclear story and toward Oklo’s actual business progress. The company continues to spend heavily on reactor development, fuel expansion projects, and long-term growth, while meaningful commercial revenue remains ahead. Its quarterly results added to those concerns, with losses coming in higher than expected and raising fresh questions about the time and capital required to reach commercialization.

That shift in sentiment has hit the stock hard. OKLO stock is now down about 79% from its record high and roughly 42% on a year-to-date (YTD) basis, highlighting how quickly momentum can reverse when expectations run ahead of fundamentals.

The technical picture remains cautious, too. The 14-day RSI sits around 44 and suggests momentum has cooled without pushing the stock into deeply oversold territory, leaving OKLO vulnerable but potentially setting the stage for a sharp reversal if buyers return.

Oklo’s Stronger-Than-Expected Revenue Offsets Q2 Loss

For Oklo, the second quarter of fiscal 2026 marked an important first—the company finally recorded revenue. Usually, a first-ever revenue print gives investors something to cheer about, and OKLO stock initially did just that, jumping 14.8% after the earnings report. But the excitement did not last long. Shares fell about 8% in the following trading session as investors focused on the company’s wider-than-expected loss.

Oklo reported $1.2 million in revenue, easily beating Wall Street’s expectations. However, its loss widened to -$0.28 per share from -$0.18 per share a year earlier and came in worse than what analysts had expected. That highlighted the bigger challenge for Oklo—the company is making progress, but it is also spending heavily to get its nuclear projects off the ground.

Cash spending is moving higher, too. Net cash used in operating activities reached $65.5 million for the first six months of 2026, up from $30.7 million a year earlier. Still, Oklo ended the period with about $1.6 billion in cash, while short-term debt was less than $1 million. So, despite the higher spending, the company maintains a strong cash cushion to fund its ambitious plans.

On the operational side, there was a more encouraging development. Oklo’s Groves Isotope Test Reactor near Lockhart, Texas, achieved first criticality in less than a year. The reactor successfully established a controlled, self-sustaining nuclear chain reaction—the first Oklo reactor to reach this milestone.

That progress could also support Atomic Alchemy, Oklo’s radioisotope business, which targets medical, industrial, and research applications.

Still, investors should expect more spending ahead. Management raised its 2026 operating cash-use forecast to $120 million to $150 million from the $80 million to $100 million range and increased its property, plant, and equipment spending outlook to $400 million to $500 million from the range of $350 million to $450 million, reflecting faster Aurora-INL activity and fuel purchases for future isotope projects.

Analysts monitoring Oklo predict the company’s losses to widen by 25% year-over-year (YoY) to -$0.90 per share in 2026 and then expand by another 10% annually to -$0.90 per share in fiscal 2027.

What Do Analysts Expect for OKLO Stock?

Despite the recent pressure on OKLO stock, Wall Street analysts still see Oklo as an interesting long-term play in the growing race for advanced nuclear power and AI-driven energy infrastructure. The stock currently carries a consensus “Moderate Buy” rating, suggesting that analysts remain hopeful about Oklo’s potential to become a major player in next-generation clean energy.

Among the 22 analysts covering the stock, 10 suggest a “Strong Buy,” and two recommend a “Moderate Buy,” while 10 remain on the sidelines with “Hold” ratings.

The average price target of $81.55 implies potential gains of 94% from current levels, while the Street-high target of $130 suggests shares could soar as much as 210% from here.